Nobody can even believe it. A 578% difference. Eli Lilly, who has been very helpful to us in getting this done, will Eli Lilly...will be cutting the cost of its common insulin drug and medication from $200 to $25. Nobody can believe it. 200 to $25. AstraZeneca is slashing the price of a common inhaler from $458 to $51, a difference of nearly 800%. (03:51–04:04)
CLAIM
Asserts that Eli Lilly will reduce the cost of its insulin drug from $200 to $25.
This is an excerpt from a raw transcript. The assertions have not been audited or verified. Tap the video to view the source footage and understand the context.
